Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma

Masaki Maruta, MD, Toshiki Ochi, MD PhD, Kazushi Tanimoto, MD PhD, Taichi Azuma, MD PhD, Hiroshi Fujiwara, MD PhD, Masaki Yasukawa, MD PhD

Blood (2017) 130 (Supplement 1): 1913.

https://doi.org/10.1182/blood.V130.Suppl_1.1913.1913

Published: 2017

Journal Articles

Co-Administration Of Gene-Modified CD4 + T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia

Hiroshi Fujiwara, MD, PhD, Fumihiro Ochi, MD, Toshiki Ochi, MD, PhD, Hiroaki Asai, MD, PhD, Yukihiro Miyazaki, MD, PhD, Taichi Azuma, MD, PhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Miwako Narita, MD, PhD, Kiyotaka Kuzushima, MD, PhD, Hiroshi Shiku, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2013) 122 (21): 144.

https://doi.org/10.1182/blood.V122.21.144.144

Published: 2013

Journal Articles

Aurora-a Kinase: A Novel Target of Cellular Immunotherapy for Human Leukemia

Toshiki Ochi, MD, Hiroshi Fujiwara, MD, PhD, Koichiro Suemori, MD, Taichi Azuma, MD, PhD, Kiyotaka Kuzushima, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2008) 112 (11): 2904.

https://doi.org/10.1182/blood.V112.11.2904.2904

Published: 2008

Journal Articles

Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.

Toshiki Ochi, MD, Hiroshi Fujiwara, MD., PhD, Kohichiro Suemori, MD, Taichi Azuma, MD., PhD, Kiyotaka Kuzushima, MD., PhD, Masaki Yasukawa, MD., PhD

Blood (2007) 110 (11): 1796.

https://doi.org/10.1182/blood.V110.11.1796.1796

Published: 2007

Journal Articles

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Yoshihiro Yakushijin, MD, PhD, Toshio Kodama, MD, PhD, Ikue Takaoka, Kazushi Tanimoto, MD, Hiroko Bessho, PhD, Jun Yamanouchi, MD, PhD, Taichi Azuma, MD, PhD, Hiroshi Narumi, MD, PhD, Takaaki Hato, MD, PhD, Hitoshi Hasegawa, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2006) 108 (11): 4626.

https://doi.org/10.1182/blood.V108.11.4626.4626

Published: 2006

NARROW

Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma

Co-Administration Of Gene-Modified CD4 + T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia

Aurora-a Kinase: A Novel Target of Cellular Immunotherapy for Human Leukemia

Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma

Co-Administration Of Gene-Modified CD4 + T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia

Aurora-a Kinase: A Novel Target of Cellular Immunotherapy for Human Leukemia

Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only